Journal of Clinical and Aesthetic Dermatology

DEC 2017

An evidence-based, peer-reviewed journal for practicing clinicians in the field of dermatology

Issue link: http://jcadonline.epubxp.com/i/918586

Contents of this Issue

Navigation

Page 17 of 59

18 JCAD JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY December 2017 • Volume 10 • Number 12 O R I G I N A L R E S E A R C H also contribute to the formation of fine lines and wrinkles and uneven skin texture. Results from this study support how a combination of HA 5 and neuromodulator injection can contribute to the development of a comprehensive approach to optimize patient outcomes. Better outcomes and perceived experience translated to great satisfaction in this study, and, if this treatment is used in practice, it might ultimately result in increased patient retention. ACKNOWLEDGMENT We would like to acknowledge Priscilla Tan, BA, employee of SkinMedica Inc., an Allergan Company, who conducted the data analysis for this study. REFERENCES 1. American Society for Aesthetic Plastic Surgery. 2016. Available at: http://www.plasticsurgery. org/news/2016/new-statistics-reflect-the- changing-face-of-plastic-surgery.html. Accessed May 16, 2016. 2. Liu F, Hamer MA, Deelen J, Lall JS, et al. The MC1R gene and youthful looks. Curr Biol. 2016;26(9):1213–1220. 3. Uitto J. The role of elastin and collagen in cutaneous aging: Intrinsic aging versus photoexposure. J Drugs Dermatol. 2008;7(2 Suppl):12–16. 4. Gilchrest BA. Skin aging and photoaging: An overview. J Am Acad Dermatol. 1989;21(3 Pt 2):610–613. 5. Carruthers JA, Bruce S, Cox SE, et. al. OnabotulinumtoxinA for treatment of moderate- to-severe crow's feet lines: a review. Aesthet Surg J. 2016;36(5):591–597. 6. Carruthers JA, Lowe NJ, Menter MA, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 2002;46(6):840–849. 7. Kerscher M, Rzany B, Prager W, et al. Efficacy and safety of incobotulinumtoxinA in the treatment of upper facial lines: results from a randomized, double-blind, placebo-controlled phase III study. Dermatol Surg. 2015;41(10):1149–1157. 8. Narukar VA, Fabi SG, Bucay VW, et al. Rejuvenating hydrator: restoring epidermal hyaluronic acid homeostasis with instant benefits. J Drugs Dermatol. 2016;15(1 Suppl 2):s24–s37. 9. Wisniewski JD, Ellis DL, Lupo MP. Facial rejuvenation: combining cosmeceuticals with cosmetic procedures. Cutis. 2014;94(3):122–126. 10. Bruce S. Complementary effects of topical antiaging treatments in conjunction with aesthetic procedures. J Drugs Dermatol. 2008;7(2 Suppl):s23–s27. 11. Cuerda-Galindo E, Palomar-Gallego M, Linares- Garcivaldecasas R. Are combined same-day treatments the future for photorejuvenation? Review of the literature on combined treatments with lasers, intense pulsed light, radiofrequency, botulinum toxin, and fillers for rejuvenation. J Cosmet Laser Ther. 2015;17(1):49–54. 12. Fabi, SG, Carruthers J. A single modality approach to rejuvenate the aging face and body: a thing of the past?. Derm Surg. 2016;42 Suppl 2:S73–S76. 13. Tierney EP, Hanke CW. Recent advances in combination treatments for photoaging: review of the literature. Dermatol Surg. 2010;36(6):829– 840. 14. Griffiths CEM, Wang TE, Hamilton TA, et al. A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol. 1992;128(3):347–351. JCAD

Articles in this issue

Archives of this issue

view archives of Journal of Clinical and Aesthetic Dermatology - DEC 2017